TABLE OF CONTENTS
Volume 36, Issue 9 (November (1) 2005)
Special Report |
Conditioning Regimens |
Pediatric Transplants |
Autografting |
Post-Transplant Events |
Graft-Versus-Host Effects |
Graft-Versus-Host Disease
Review
What would Karl Landsteiner do? The ABO blood group and stem cell transplantation FREE
J M Heal, J L Liesveld, G L Phillips and N Blumberg
Bone Marrow Transplant 36: 747-755; advance online publication, July 25, 2005; doi:10.1038/sj.bmt.1705101
Special Report
Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time FREE
A Gratwohl, R Brand, F Frassoni, V Rocha, D Niederwieser, P Reusser, H Einsele and C Cordonnier for the Acute and Chronic Leukemia Working Parties and the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
Bone Marrow Transplant 36: 757-769; advance online publication, September 5, 2005; doi:10.1038/sj.bmt.1705140
Conditioning Regimens
Optimizing the use of anti-interleukin-6 monoclonal antibody with dexamethasone and 140 mg/m2 of melphalan in multiple myeloma: results of a pilot study including biological aspects FREE
J-F Rossi, N Fegueux, Z Y Lu, E Legouffe, C Exbrayat, M-C Bozonnat, R Navarro, E Lopez, P Quittet, J-P Daures, V Rouillé, T Kanouni, J Widjenes and B Klein
Bone Marrow Transplant 36: 771-779; advance online publication, August 22, 2005; doi:10.1038/sj.bmt.1705138
Pediatric Transplants
Long-term outcome of allogeneic PBSC transplantation in pediatric patients with hematological malignancies: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON) and the Spanish Group for Allogeneic Peripheral Blood Transplantation (GETH) FREE
M A Diaz, M Gonzalez-Vicent, M E Gonzalez, A Verdeguer, A Martinez, M Perez-Hurtado, I Badell, J de la Rubia, J Bargay, F de Arriba, J L Diez, D Caballero, L Madero and S Brunet
Bone Marrow Transplant 36: 781-785; advance online publication, September 5, 2005; doi:10.1038/sj.bmt.1705135
Hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: experience of the French neutropenia registry FREE
J Donadieu, G Michel, E Merlin, P Bordigoni, B Monteux, B Beaupain, G Leverger, J P Laporte, O Hermine, A Buzyn, Y Bertrand, J L Casanova, T Leblanc, E Gluckman, A Fischer and J L Stephan
Bone Marrow Transplant 36: 787-792; advance online publication, September 5, 2005; doi:10.1038/sj.bmt.1705141
Autografting
Genetic risk identifies multiple myeloma patients who do not benefit from autologous stem cell transplantation FREE
H Chang, X Y Qi, S Samiee, Q-L Yi, C Chen, S Trudel, J Mikhael, D Reece and A K Stewart
Bone Marrow Transplant 36: 793-796; advance online publication, August 22, 2005; doi:10.1038/sj.bmt.1705131
Post-Transplant Events
Cytomegalovirus (CMV) infections and CMV-specific cellular immune reconstitution following reduced intensity conditioning allogeneic stem cell transplantation with Alemtuzumab FREE
R Lamba, G Carrum, G D Myers, C M Bollard, R A Krance, H E Heslop, M K Brenner and U Popat
Bone Marrow Transplant 36: 797-802; advance online publication, September 5, 2005; doi:10.1038/sj.bmt.1705121
Evaluation of cytomegalovirus-specific cytotoxic T-lymphocytes in patients with the HLA-A*02 or HLA-A*24 phenotype undergoing hematopoietic stem cell transplantation FREE
Y Morita, M Hosokawa, M Ebisawa, T Sugita, O Miura, Y Takaue and Y Heike
Bone Marrow Transplant 36: 803-811; advance online publication, August 22, 2005; doi:10.1038/sj.bmt.1705133
High-grade cytomegalovirus antigenemia after hematopoietic stem cell transplantation FREE
Y Asano-Mori, K Oshima, M Sakata-Yanagimoto, M Nakagawa, K Kandabashi, K Izutsu, A Hangaishi, T Motokura, S Chiba, M Kurokawa, H Hirai and Y Kanda
Bone Marrow Transplant 36: 813-819; advance online publication, September 5, 2005; doi:10.1038/sj.bmt.1705134
Cardiac complications after haploidentical HLA-mismatched hematopoietic stem cell transplantation using in vivo alemtuzumab FREE
K Oshima, M Sakata-Yanagimoto, Y Asano-Mori, K Izutsu, T Watanabe, E Shoda, S Ogawa, T Motokura, S Chiba, M Kurokawa, H Hirai and Y Kanda
Bone Marrow Transplant 36: 821-824; advance online publication, August 22, 2005; doi:10.1038/sj.bmt.1705145
Graft-Versus-Host Effects
Myeloablative allografting for chronic lymphocytic leukemia: evidence for a potent graft-versus-leukemia effect associated with graft-versus-host disease FREE
C L Toze, A Galal, M J Barnett, J D Shepherd, E A Conneally, D E Hogge, S H Nantel, T J Nevill, H J Sutherland, J M Connors, N J Voss, T L Kiss, H A Messner, J C Lavoie, D L Forrest, K W Song, C A Smith and J Lipton
Bone Marrow Transplant 36: 825-830; advance online publication, September 5, 2005; doi:10.1038/sj.bmt.1705130
Graft-Versus-Host Disease
OKT3 muromonab as second-line and subsequent treatment in recipients of stem cell allografts with steroid-resistant acute graft-versus-host disease FREE
S Knop, H Hebart, H Gscheidle, E Holler, H-J Kolb, D Niederwieser and H Einsele
Bone Marrow Transplant 36: 831-837; advance online publication, September 5, 2005; doi:10.1038/sj.bmt.1705132
